Former President Joe Biden has completed a course of radiation therapy as he battles prostate cancer, a spokesperson for Biden told CNN. It is unclear what Biden’s next treatment steps might be. The ...
Victor Sung, M.D., director of the Division of Movement Disorders in the University of Alabama at Birmingham Department of Neurology and director of the UAB Huntington’s Disease Clinic, reacted to the ...
A new treatment that proves to slow the progression of Huntington’s disease (HD) marks a breakthrough for a condition that has long been considered untreatable. Huntington’s is a rare, inherited ...
Every week neurologist Victor Sung sees people with Huntington’s disease, a rare and deadly neurodegenerative disorder, at his clinic at the University of Alabama at Birmingham. But a Wednesday in ...
A gene therapy injected into patients’ brains slowed progression of the disease by 75 percent, preliminary findings reported. By Dana G. Smith Preliminary results from a small clinical trial to treat ...
With informed consent, you generally have the right to seek a second opinion or refuse treatment unless refusing poses a danger to the community or a court of law declares you “mentally incompetent.” ...
Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...
Functional gonadotroph adenoma (FGA) is a rare condition associated with secretion of biologically active gonadotropins which affect reproductive organs. In women of reproductive age, it has been ...
ROANOKE, Va. (WDBJ) - A growing number of people in Central Virginia are being diagnosed with Alpha-Gal Syndrome. It’s an allergy caused by tick bites that makes eating—or even being near—meat or ...
Shawn Connolly, a former skateboarding professional, follows the directions of Nicholas B. Galifianakis, MD, while testing a deep brain stimulation treatment for Parkinson’s disease. Photo by Maurice ...
Hidradenitis suppurativa is managed with biologics like adalimumab and secukinumab, approved for moderate-to-severe cases. Adalimumab, a TNF-α inhibitor, was FDA-approved in 2015, while secukinumab, ...